Question 26

A materials supplier informs a company that it intends to stop supplying a material critical to the manufacture of the company's products. What action should the company take FIRST?
  • Question 27

    At a recent scientific meeting, Company Y had two booths:
    * At one booth, Company Y provided brochures on a completed Phase II study.
    * In an adjacent booth, Company Y's sales professionals were promoting one of Company
    Y's marketed products.
    A regulatory affairs-professional at Company X sends a letter to a counterpart at Company
    Y requesting that Company Y stop this practice in the future and demanding a formal response to the letter. How should the regulatory affairs professional at Company Y BEST respond?
  • Question 28

    Which of the following claims would classify an apple as a drug?
  • Question 29

    A company is developing a new line of products in an area that is new to the company.
    What is the BEST approach?
  • Question 30

    A company is developing a device-drug combination product. Which of the following should be evaluated FIRST in order to determine the applicable guidance documents?